Millennium Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Millennium Management’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-75,244	Closed	-$4.5M	–	5030
2020 Q2	$4.5M	Sell	75,244 -5,240	-7%	-$324K	0.01%	1873
2020 Q1	$4.78M	Buy	+80,484	New	+$4.69M	0.01%	1361
2019 Q3	–	Sell	-38,716	Closed	-$1.28M	–	4732
2019 Q2	$1.28M	Buy	38,716 +19,250	+99%	+$601K	﹤0.01%	2653
2019 Q1	$662K	Buy	19,466 +8,872	+84%	+$282K	﹤0.01%	3103
2018 Q4	$290K	Sell	10,594 -131,331	-93%	-$3.38M	﹤0.01%	3230
2018 Q3	$4.15M	Buy	+141,925	New	+$4.01M	0.01%	1945

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Millennium Management's PRNB Position: Q3 2020 in Review

Millennium Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 75,244 shares — an estimated $4.5M sold.

Millennium Management first reported a position in PRNB in Q3 2018 and held it in 6 quarters. The position peaked at $4.78M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Millennium Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Millennium Management sold 75,244 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $4.5M.
Millennium Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 6 quarters.
Millennium Management's Principia Biopharma Inc. Common Stock position peaked at $4.78M in Q1 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.